Polyunsaturated fatty acids (PUFAs) are organic fatty acids that are essential for human health but cannot be synthesized in the body. They play an important role in brain function, inflammation and heart health. The two major types of PUFAs are omega-3 and omega-6 fatty acids. Omega-3 fatty acids such as ALA, EPA, and DHA have demonstrated ability to reduce risk of heart disease and promote brain and eye health. Similarly, omega-6 linoleic acid plays an important role in growth and development. These health benefits have led to a rise in demand for PUFA supplements and PUFA-fortified food products.

The global Polyunsaturated Fatty Acids Market is estimated to be valued at Us$ 6.36 Billion in 2023 and is expected to exhibit a Cagr Of 5.3% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

Growing Demand for Omega-3 and Omega-6 Fatty Acids: Growing health consciousness among consumers and rising prevalence of lifestyle diseases have raised awareness about importance of omega-3 and omega-6 fatty acids. Research studies have demonstrated role of these fatty acids in reducing risk of heart disease, stroke, depression and promoting brain and eye health. This has driven demand for PUFA supplements, functional foods and beverages fortified with omega-3 and omega-6.

Rising Awareness about Health Benefits of PUFAs: Various government and healthcare organizations are undertaking initiatives to educate people about importance of maintaining a balanced diet with omega-3 and omega-6 rich foods. Celebrity endorsements and social media influence have also contributed to widespread promotion of health benefits of PUFAs. Such awareness campaigns have fueled adoption of PUFA-fortified food products among health-conscious consumers.

Segment Analysis

The polyunsaturated fatty acids market is segmented into omega-3 and omega-6 types. The omega-3 segment dominates the market and accounts for over 60% share owing to growing health benefits associated with consumption of omega-3 fatty acids. Within omega-3, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) sub-segments hold major share due to increasing applications in infant formula, pharmaceuticals and supplements industries.

PEST Analysis

Political: Strict regulations regarding usage of PUFAs in food applications provide stable growth pathways for players.

Economic: Rising health consciousness and disposable income in emerging nations drive demand.

Social: Growing vegan population promote algae-based PUFAs.

Technological: New extraction methods help lower costs and reduce environmental impact.

Key Takeaways

The Global Polyunsaturated Fatty Acids Market Demand is expected to witness high growth over the forecast period. The global Polyunsaturated Fatty Acids Market is estimated to be valued at US$ 6.36 Bn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030.

Regional analysis

North America accounts for over 40% of global polyunsaturated fatty acids market share led by US and Canada. This is attributed to high health consciousness among consumers and booming nutraceuticals sector in the region. Asia Pacific region exhibits fastest growth on back of expanding food processing and pharmaceutical industries in China and India along with rapidly growing middle class population.

Key players

Key players operating in the polyunsaturated fatty acids market are Koninklijke DSM N.V, BASF SE, Croda International PLC, Enzymotec Ltd., Omega Protein Corporation, Aker Bio Marine AS, Polaris Nutritional Lipids, FMC Corporation, Cargill, Incorporated, GlaxoSmithKline plc. Koninklijke DSM N.V leads the market with wide array of omega-3 and omega-6 products catering to diverse industrial applications. BASF SE focuses on algal DHA and EPA concentrates to target vegan population.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it